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RESEARCH ARTICLE
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Abstract
Intact red blood cells (RBCs) are required for phenotypic analyses. In order to allow separa-
tion (time and location) between subject encounter and sample analysis, we developed a
research-specific RBC cryopreservation protocol and assessed its impact on data fidelity for
key biochemical and physiological assays. RBCs drawn from healthy volunteers were ali-
quotted for immediate analysis or following glycerol-based cryopreservation, thawing, and
deglycerolization. RBC phenotype was assessed by (1) scanning electron microscopy
(SEM) imaging and standard morphometric RBC indices, (2) osmotic fragility, (3) deform-
ability, (4) endothelial adhesion, (5) oxygen (O2) affinity, (6) ability to regulate hypoxic vaso-
dilation, (7) nitric oxide (NO) content, (8) metabolomic phenotyping (at steady state, tracing
with [1,2,3-13C3]glucose ± oxidative challenge with superoxide thermal source; SOTS-1), as
well as in vivo quantification (following human to mouse RBC xenotransfusion) of (9) blood
oxygenation content mapping and flow dynamics (velocity and adhesion). Our revised gly-
cerolization protocol (40% v/v final) resulted in >98.5% RBC recovery following freezing
(-80˚C) and thawing (37˚C), with no difference compared to the standard reported method
(40% w/v final). Full deglycerolization (>99.9% glycerol removal) of 40% v/v final samples
resulted in total cumulative lysis of
~
8%, compared to
~
12–15% with the standard method.
The post cryopreservation/deglycerolization RBC phenotype was indistinguishable from
that for fresh RBCs with regard to physical RBC parameters (morphology, volume, and
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density), osmotic fragility, deformability, endothelial adhesivity, O2 affinity, vasoregulation,
metabolomics, and flow dynamics. These results indicate that RBC cryopreservation/degly-
cerolization in 40% v/v glycerol final does not significantly impact RBC phenotype (com-
pared to fresh cells).
Introduction
Red blood cell (RBC) cryopreservation was described almost seventy years ago[1] and subse-
quently explored as means to prolong RBC storage prior to transfusion[2, 3]. Of note, RBC
cryopreservation has never been optimized to satisfy research requirements, which differ from
those for clinical use.
The main challenge in cryopreservation (i.e., the use of very low temperature to preserve
intact cells[4]) is not endurance of extremely low temperature, but rather that of an intermedi-
ate temperature zone (approx. between -10 to -60˚C) to which cells are exposed twice–during
cooling and warming[5]. This intermediate temperature zone may damage cells due to imbal-
anced transmembrane water transport, a temperature-dependent process[6]. If water is not
given enough time to exit, injury occurs from intracellular ice formation (IIF), leading to
mechanical shearing[6, 7]. However, if water exits too quickly, injury may result from cell
shrinkage and related changes in intracellular solute concentrations (“solution effects” injury)
[8, 9]. Between these two ends of the spectrum, optimal cooling and warming rates exist that
minimize freezing injury[10, 11].
Cryoprotective agents (CPAs) modulate membrane water transport[4] and inhibit intracel-
lular ice formation. The most widely used CPA for RBC cryopreservation is glycerol, which
enters cells via facilitated transport[12], whilst remaining nontoxic at high concentrations[13].
Two RBC glycerol cryopreservation protocols have been developed[14]: the high-glycerol
(HGM; ~40%-50% w/v)[15, 16] and low-glycerol methods (LGM; ~15–20% w/v)[17, 18]
(Table 1). We focused on a HGM (40% v/v), due to material and equipment availability and
simpler sample transport, on dry ice rather than in liquid nitrogen, which LGM requires.
Adoption of glycerol-based RBC cryopreservation has been limited due to cost (money and
time) of the deglycerolization process[28–30]. To prevent hypo-osmotic hemolysis during
CPA removal, manual washing techniques have been developed using aqueous sugar[31] or
salt[28]. Additionally, an automated system has been developed for clinical use[14], in which:
(1) residual glycerol concentration is below threshold for hemolysis (of endogenous RBCs)
Table 1. Comparison of the high-glycerol (HGM) and low-glycerol (LGM) methods for the cryopreservation of
human RBCs.
CONDITIONS HGM (~40–50% w/v) LGM (~15–20% w/v)
Freezing Temperature -80˚C -197˚C
Freezing Rate Slow (1C/min) Fast
Freezing Technique Mechanical freezer Liquid nitrogen
Storage Temperature Min. -65˚C Min. -120˚C
Impact of temperature changes Thawing/refreezing possible Highly destructive
Transportation Dry ice Nitrogen vapor
Time to deglycerolize Lengthy (60 min) Moderate (30 min)
Typical lysis following thaw 1–5% [19–22] 2–20% [18, 23, 24]
Typical lysis following CPA removal 10–20% [19–23, 25–27] 5–13% [18, 23]
https://doi.org/10.1371/journal.pone.0209201.t001
Cryopreserved red cell biochemistry and physiology
PLOS ONE | https://doi.org/10.1371/journal.pone.0209201 December 21, 2018 2 / 21
Competing interests: The authors have declared
that no competing interests exist.
[29], (2) final wash hemolysis is<1%, and (3) 24h post-transfusion RBC recovery is >75%,
meeting current regulatory requirements[32]; however, total RBC loss is typically ~15%[20].
This may be of clinical benefit, by culling damaged/senescent cells prior to transfusion. How-
ever, for research the goal is to obtain a RBC population identical to that circulating in subjects.
Moreover, the most vulnerable cells are likely of greatest interest.
RBC assessment following cryopreservation has focused on basic in vitro analyses (hemoly-
sis[2, 3, 21], morphologic[2, 33], rheologic[34], osmotic[2, 33, 34], surface marker[35], and
biochemical[2, 3, 33]) and on in vivo survival[3, 21, 36], rather than on physiologic function
(O2 transport, NO processing, vasoreactivity, and metabolism). Given new understanding of
the pivotal role played by RBCs in vasoregulation[37], such analyses are relevant as well. Since
such phenotypic analyses require intact cells, research has been limited by subject availability/
proximity. To enable separation between subject and sample analysis, we identified need for
research-optimized RBC cryopreservation, with simplified processing and maximized fidelity
of recovered cells to in vivo phenotype. To achieve these goals, we developed a novel glyceroli-
zation procedure, minimizing front-end processing time. Additionally, we optimized a degly-
cerolization protocol, assessing sample osmolality and CPA removal at each step, thereby
minimizing RBC lysis. Finally, to assess cryopreservation impact, we compared the phenotypic
profile of cryopreserved/deglycerolized RBCs to that of fresh RBCs.
Methods
Blood sampling and preparation of RBCs
This project was approved by the Washington University and Duke IRBs and written informed
consent was obtained from all participants. Venous samples (EDTA or heparinized) were
drawn from healthy volunteers. Unless otherwise stated, whole blood was centrifuged (1,500–
2,000g, 10min, 4˚C); plasma supernatant and buffy coat were removed prior to RBC prepara-
tion. All subsequent steps were carried out at RT, given that glycerol flux into RBCs is tempera-
ture dependent[38].
Standard glycerolization
We followed a scaled-down step-wise cryopreservation procedure (40% w/v glycerol final), as
reported[28, 38, 39] (S1 Extended Methods). Total processing time was ~25min (Fig 1A). Gly-
cerolized samples were then placed into a Coolcell freezing container (Biocision, Larkspur,
CA), ensuring rate-controlled freezing (-1˚C/min when placed into a -80˚C freezer).
Adapted glycerolization
We then modified the cryopreservation process to shorten processing and to allow collection
of smaller sample volumes, more appropriate for research analysis (Fig 1A). Initial collection
and centrifugation were unchanged from the standard protocol. Briefly, RBCs (300μl) were ali-
quoted from the bottom of the RBC pellet into cryopreservation tubes containing 300μl buffer
and 300μl buffer/glycerol stock (60% v/v glycerol in starting buffer solution). Immediately
thereafter, samples were mixed gently by repeated inversion, after which additional PBS-glyc-
erol (900μl, 60% v/v glycerol in starting buffer solution) was added and the samples were again
inverted (glycerol final 40% v/v; see S1 Extended Methods). Samples were then placed into a
Coolcell freezing container. Matched fresh RBC samples were processed (washed 3X in PBS)
for immediate analysis.
Cryopreserved red cell biochemistry and physiology
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Fig 1. Optimization of an adapted glycerolization procedure and comparison to the standard reported literature method. (A) Diagram of the standard
glycerolization protocol and our adapted method, designed to minimize sample processing time and allow collection/processing/storage of smaller RBC aliquots. In
the standard glycerolization method, RBC volumes were added dropwise resulting in a final solution that was 40% w/v glycerol; in the adapted method, RBCs were
added as a bolus, resulting in a final 40% v/v glycerol solution. All centrifugation was performed at 1,500g, 5min, at 4˚C. (B) Whisker-plot comparing RBC lysis
resulting from the addition of buffer/glycerol (60% v/v glycerol buffer stock added to samples) at different temperatures to pRBCs in a one step (bolus addition;
300μl pRBC to 600μl buffer/glycerol stock) or two step (300μl pRBCs to 300μl buffer to 300μl buffer/glycerol stock = step one, followed by addition of further 900μl
buffer/glycerol stock = step two) process. Note, both procedures resulted in a 40% v/v glycerol final. Additionally in this experiment, no samples were frozen.
Glycerol solutions were added and then samples immediately centrifuged and lysis measured. (C) Whisker-plot comparing the order of addition of pRBC, buffer,
and buffer/glycerol (60% v/v glycerol buffer stock added to samples) in the two step glycerolization procedure, on the amount of lysis following sample freezing at
Cryopreserved red cell biochemistry and physiology
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Deglycerolization
Cryopreserved samples (40% v/v glycerol final) were thawed (37˚C, 2min), inverted to mix,
then transferred to Eppendorf tubes for centrifugation (1,500g, 5min, RT). The majority of
supernatant (~1.4ml) was removed, leaving ~100μl layering the RBC pellet (~300μl); this resid-
ual was inverted to gently resuspend RBCs (~ 75% Hct) for subsequent deglycerolization.
Standard deglycerolization
We consolidated the published standard serial dilution procedure[28, 39]; deglycerolizing
solutions were: 12% NaCI, 1.6% NaCI (unbuffered), followed by isotonic wash (0.8% NaCI,
0.2% glucose (11 mM), pH 7.4) (Table 2). The process required ~50min (Fig 2A) (see S1
Extended Methods).
Adapted deglycerolization
We optimized the above method to minimize RBC lysis by extending the dilution sequence
(reducing osmolality less rapidly). The process required ~1hr (Fig 2A) (see S1 Extended
Methods).
RBC lysis
To determine the extent of RBC lysis, we assayed Hb concentration ([Hb]) spectrophotometri-
cally (Biotek μQuant, Winooski, VT or FLUOstar Omega, BMG Labtech, Cary, NC) in both
the post-centrifugation supernatant (numerator) and the original RBC-glycerol suspension
(denominator), accounting volumes of each, and multiplying by 100 to index hemolysis to the
starting total [Hb]. [Hb] assays and calculation of lysis percentage were repeated at each stage
following cryopreservation, at various points during deglycerolization (Fig 2A) and successive
washes. An alternative lysis calculation is outlined in S1 Extended Methods. [Hb] values from
supernatants and RBC lysates did not differ whether measured by simple spectrophotometric
or Drabkin’s assays, using the following formula:
Heme mMð Þ ¼
ðsample absorbance @ 540 nMÞ X ðdilution factorÞ
ðextinction coefficient @ 540 nMÞ X ðpathlength correctionÞ
where the extinction coefficient was 11mM-1cm-1 (this extinction coefficient is for the product
of the reaction between Drabkins reagent and hemoglobin, i.e., cyanomethemoglobin) and the
pathlength correction was 0.8 for a 300μl volume in a 96-well plate.
-80˚C and thawing for 2 minutes at 37˚C. Order of addition of components is highly important. (D) Whisker-plot comparing RBC lysis following sample freezing
and thawing, for the standard (40% w/v glycerol final) and our adapted (40% v/v glycerol final) glycerolization procedure. Mean RBC lysis was not different between
the two methods; however, our adapted glycerolization procedure was 40% more time efficient (n = 9 matched samples from 3 individual blood donors).
https://doi.org/10.1371/journal.pone.0209201.g001
Table 2. Characteristics of the buffers used in sample glycerolization and deglycerolization.
Buffer Molarity NaCl (%) Osmolality (mOsm) pH
PBS-glycerol (60% v/v glycerol in PBS) 10 mM - 8100 7.4
PBS 10 mM - 280 7.4
Wash buffer 1 (12% NaCl) 2.05 M 12 3700 Unbuff
Wash buffer 2 (1.6% NaCl) 274 mM 1.6 530 Unbuff
Wash buffer 3 (0.8% NaCl + 0.2% glucose) 137 mM 0.8 290 7.4
https://doi.org/10.1371/journal.pone.0209201.t002
Cryopreserved red cell biochemistry and physiology
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Fig 2. Comparison of the standard and our adapted deglycerolization procedure. (A) Diagram of the standard
deglycerolization protocol and our adapted method, designed to reduce RBC lysis. Samples (40% v/v glycerol final) were thawed
(2min, 37˚C), then centrifuged (1,500g, 5min, 4˚C). For equilibration, samples were left undisturbed for 3min at RT. Circled
numbers identify sampling points for the graphs presented in B-D. (B) Sample osmolality was measured at various stages of the
standard and adapted deglycerolization methods. The adapted method slowed osmolality reduction during de-gycerolization,
thereby protecting cells from lysis (n = 3–8 samples from 3 individual blood donors). (C) Total cumulative RBC lysis measured at
different stages of the standard and adapted deglycerolization methods. RBC lysis was significantly reduced using the adapted
deglycerolization method (n = samples, shown on graph. Minimum number of individual blood donors = 4). (D) Intracellular
RBC glycerol measured at different stages of the standard and adapted deglycerolization methods. Both methods result in total
glycerol removal (> 99.9%) (n = 4–6 samples from 3 individual blood donors).
https://doi.org/10.1371/journal.pone.0209201.g002
Cryopreserved red cell biochemistry and physiology
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Sample osmolality
Osmolality was determined by freezing point depression (Osmette A, Precision Systems Inc,
Natick, MA).
Intracellular RBC glycerol concentration
Intracellular glycerol was determined using a Glycerol Assay kit (Sigma MAK117) and mea-
sured spectrophotometrically (A570; Biotek μQuant, Winooski, VT) (see S1 Extended
Methods).
Scanning electron microscopy
See S1 Extended Methods for details; briefly, RBCs were fixed to poly-L-lysine coated cover-
slips, dehydrated in ethanol, dried (Leica EM CPD 300, Vienna, Austria), mounted on alumi-
num stubs and sputter coated with iridium (Leica ACE 600, Vienna, Austria), then loaded into
a FE-SEM (Zeiss Merlin, Oberkochen, Germany) and imaged (3KeV, 300pA) using the Ever-
hart Thornley secondary electron detector. Cell morphology was quantitated using a standard
method[40]. Briefly, three separate images of cells (~50–200 cells per image), either fresh, gly-
cerolized, thawed, or deglycerolized, were counted and categorized according to shape, into
one of six classes; (a) smooth disc (1.0), (b) crenated disc (0.8), (c) crenated discoid (0.6), (d)
crenated spheroid (0.4), (e) crenated sphere (0.2), (f) smooth sphere (0). The percentage of
each cell type was multiplied by the factor assigned to each cell type (in parentheses above),
and the sum of these products was added together to calculate the morphological index (Im).
Standard RBC indices (CBC)
Standard RBC parameters including: mean corpuscular volume (MCV), mean corpuscular
hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), and red cell dis-
tribution width (RDW) were measured using a conventional analyzer (Coulter ACT diff2,
Beckman, Brea, CA).
Osmotic fragility
Washed RBCs (50μL) were suspended in NaCl solutions (5ml) ranging from 0-10g/L and incu-
bated (30min, RT). Intact RBCs were pelleted (2,000g, 10min, 4˚C) and supernatant absor-
bance was read (540nm, Biotek μQuant, Winooski, VT). 100% lysis was assigned to the 0g/L
NaCl solution, against which others were indexed.
RBC deformability
RBCs in PBS (20μl, 40% Hct) were added to iso-osmolar polyvinylpyrrolidone (5ml, viscosity
~30mPa�s) (Mechatronics, Netherlands); RBC deformability (elongation index at 37˚C and
0.3–30 Pa) was measured by ektacytometry (Laser-assisted Optical Rotational Red Cell Ana-
lyzer (LORRCA), RR Mechatronics, Hoorn, Netherlands).
RBC adhesion (ex vivo)
RBC adhesivity to endothelium, in a custom variable height plexiglass flow chamber, was
determined as described[41–44] (see S1 Extended Methods). Labeled RBCs (fluorescent dye
PKH26) were introduced to the chamber (1.5ml/min), then allowed to dwell for 5–10min. The
cell number at each location (height) was recorded. Then, 5–10min of fluidic flow was con-
ducted with PBS at rates calculated to produce shear stress ranging 1–10dynes/cm2 and the
Cryopreserved red cell biochemistry and physiology
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number of adherent cells at each location was re-counted. Shear stress and percent adhesion
were calculated at each height.
O2 affinity
O2-hemoglobin dissociation curves (ODC) were determined in vitro (Hemox-Analyzer, TSC
Scientific, New Hope, PA). The p50 (pO2 at which HbSO2 is 50%) was extrapolated; the Hill
co-efficient was also calculated from these data (TCS Hemox Data Aquisition System, TCS Sci-
entific Corp, New Hope, PA).
RBC vasoactivity (hypoxic vasodilation, HVD)
Male New Zealand white rabbits (n = 7; 1.8-2kg; strain code 052, Charles River) were eutha-
nized (IV pentobarbital). The aorta was harvested and endothelium-intact rings were prepared
for isometric tension recordings (Radnoti vascular ring array, Harvard Apparatus, Holliston,
MA): 2gm resting tension, 37˚C, Krebs, as described[45]. For each experiment, eight rings
were run in parallel; n = 1 represents data averaged from rings with functional endothelium
(>60% ACh-induced relaxation following PE-induced pre-constriction)[45, 46]; percentage
relaxation was calculated as the RBC-induced decrease in tension indexed to baseline plateau
tension (during hypoxia; (95% N2 and 5% CO2)[46].
RBC NO content
Hb from fresh, frozen (without cryopreservation) and cryopreserved RBCs (deglycerolized or
not) was assayed for total, Fe-bound and thiol-bound NO (SNO) content by photolysis/chemi-
luminescence, as described[47]. No sample treatment was used, other than desalting (G25)
and paired analyses with/without HgCl2 (6-fold molar excess over [Hb thiol])[48, 49].
Metabolomics
Metabolomics analyses and tracing experiments with [1,2,3-13C3]glucose were performed, as
described[50, 51]. Either washed fresh, or glycerolized, frozen, thawed and deglycerolized
RBCs (denoted deglycerolized; DG) were incubated with [1,2,3-13C3]glucose in the presence of
(i) PBS (control), (ii) DMSO (vehicle control), or (iii) SOTS1 (superoxide donor) dosed to gen-
erate superoxide levels in the physiologically relevant range produced by activated NADPH
oxidase[52, 53]. Sampling was performed at 0, 1, 3 and 6hrs from separated cells and superna-
tants (2,000g, 10min, 4˚C). Catabolism of [1,2,3-13C3]glucose generates distinct lactate isotopo-
logues, namely 13C2 (M+2) and
13C3 (M+3), depending on whether glucose oxidation
preferentially occurs through the pentose phosphate pathway (PPP) or the Embden-Meyer-
hof-Parnas (EMP) glycolytic pathway, respectively.
Samples were prepared for UHPLC-MS metabolomics, as described[50] (also, see S1
Extended Methods). The Q Exactive mass spectrometer (Thermo, Bremen, Germany) was
operated in Full MS mode (2μscans) at 70,000 resolution in the 60-900m/z range, 4kV spray
voltage, 15 sheath gas and 5 auxiliary gas, in positive and negative ion modes (separate runs).
Metabolite assignments and isotopologue distributions were determined using the software
Maven (Princeton, NJ)[54] and assignments confirmed against 700 standards (IROATech,
Sigma Aldrich, St. Louis, MO).
Partial-Least Square Discriminant Analysis (PLS-DA), hierarchical clustering analysis
(Pearson correlation, complete linkage) and heat maps were plotted with MetaboAnalyst 4.0
[55] and GENE E (Broad Institute, Cambridge, MA).
Cryopreserved red cell biochemistry and physiology
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In vivo analysis of RBC adhesion, RBC velocity, and Hb saturation
Nude mice (n = 16; Foxn1nu; Jackson Labs, strain 002019) were anesthetized (isoflurane) and
fitted with a dorsal window chamber, as described[56]. After recovery (1-3d), mice were anes-
thetized (isoflurane), placed upon a temperature-controlled platform and inspected to verify
intact microcirculation. PKH-26 labeled RBCs (10μL/g body weight) were infused over 10sec
and label movement was tracked by intravital microscopy (5X, Zeiss Axioobserver Z1, Zeiss
Zen software). Videos (transmission and red fluorescent channel) and still images of the
microvasculature were captured for each subject and analyzed offline for RBC adhesion, RBC
velocity, and Hb saturation (ImageJ, NIH)(MatLab R2017b, Mathworks)[57].
Adhesion was measured by time-averaging a ~60sec sequence, yielding a composite image
in which adherent cells appeared as distinct fluorescent entities, while moving cells blurr. Indi-
vidual adherent RBCs were then hand-counted. Adhesion values for each subject were calcu-
lated and presented as percent adherent cells relative to total cells present in a single frame.
To measure RBC velocity, five venules of various sizes were randomly selected from each
subject’s video. Individual RBCs were selected from these venules, then tracked through 5–10
frames of movement. Because individual RBC velocities through different venules is non-uni-
form, two cells were selected from a particular venule and their velocities through a shared seg-
ment of that venule were averaged. Venule diameter was measured perpendicular to the mid-
point of the travel path. Each two-cell velocity average was then normalized to the inverse
square of the radius of the venule segment through which the cells passed. This provided five
normalized RBC velocities per subject, which were then averaged to yield a single (n = 1) aver-
age radius2-normalized RBC velocity per subject.
To measure Hb saturation, still images of each subject were taken at a range of wavelengths
and processed (Matlab) to generate a Hb saturation heat map of the region’s venules[56]. Five
segments corresponding to those used for the velocity analysis were selected for each subject.
The Hb saturation values of these segments were averaged to give a single final averaged Hb
saturation percentage value for each subject.
Statistical analyses
Results are presented as mean ± standard error of the mean (SEM). Column statistics were
performed to determine data distribution normality. Where appropriate, groups were com-
pared by t-test (Student’s or Wilcoxon rank) or repeated measures analysis of variance (RMA-
NOVA; Bonferroni’s posthoc test) (PRISM, GraphPad Inc.; La Jolla, CA).
Results
RBC glycerolization
We initially attempted glycerolizing RBCs in one-step, adding 60% v/v buffer/glycerol solution
to pelleted RBCs (40% v/v, glycerol final). The effect of temperature on this process was signifi-
cant, with warmer glycerol resulting in less RBC lysis (Fig 1B). This method resulted in lysis
(prior to freezing) of ~10%, which we considered unacceptable. We then optimized a two-step
method (similar to that reported[28, 38, 39]). We found the order of component addition to
strongly influence hemolysis; adding buffer (PBS 300μl) and 300μl buffer/glycerol stock (60%
v/v glycerol in starting buffer solution) to the tube first, followed by RBCs (300μl), resulted in
lowest lysis (Fig 1C). We also tested thawing temperature (37˚C vs 50˚C) as well as different
cryopreservative tubes (Biocision TruCool cryogenic vials #BCS-2502 and 2504, Larkspur, CA;
Corning cryogenic vials # 430487, NY; ThermoFisher Scientific Abgene storage tubes #
AB1411, Waltham, MA) and tube sizes (TruCool, Biocision, Larkspur, CA # BCS-2502, #BCS-
Cryopreserved red cell biochemistry and physiology
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2504), but no significant differences were observed (not shown). In comparison to standard
glycerol cryopreservation[38, 39], our adapted procedure (Fig 1A) resulted in similar % lysis
(1.18% ± 0.2% vs 0.88% ± 0.1%, standard vs adapted, respectively; Fig 1D), following sample
freeze/thaw (-80˚C overnight in a Coolcell and next-day thawing (37˚C, 2min)); of note, sam-
ple processing time was reduced by 40% (from 25 to 15min).
RBC deglycerolization
With the standard deglycerolization method[28, 39] (Fig 2A), we observed total cumulative
lysis of 13.0% ± 1.5%, from thawing to complete glycerol removal (Fig 2C). Consequently, to
reduce lysis, we slowed the rate at which osmolality was lowered during deglycerolization (Fig
2B). With this adapted method, total cumulative lysis fell to 8.4% ± 0.3% (p<0.05, ~ 35%
reduction) (Fig 2C). Glycerol concentration was measured to ensure full CPA removal
(>99.9% for both the standard and adapted deglycerolization protocols, Fig 2D).
Standard morphological imaging (SEM) and measurement (CBC)
SEM images were acquired at each stage of sample assessment (Fig 3A and S1 Fig). Fresh
RBCs demonstrated the characteristic bi-concave disc shape, with minimal morphological var-
iance. Following glycerolization, the majority of cells appeared spherocytic, as reflected in the
low morphological index (Im = 40.6 ± 2.1). After thawing, RBCs were observed to be embed-
ded in a highly structured cryopreservation matrix, with almost all cells demonstrating a cre-
nated sphere morphology (Im = 20.1 ± 0.1). Following full deglycerolization, cell morphology
was indistinguishable from that for fresh RBCs, with no significant difference in morphologi-
cal index (Im = 97.1 ± 1.1 vs 99.1 ± 0.2, respectively; paired t-test p = 0.26).
RBC morphometric indices complemented the qualitative SEM images. Compared to fresh
RBCs, glycerolization increased MCV (91.2 ± 2.1fL vs 109.7 ± 1.7fL; p<0.05; S1 Fig), without
altering MCH (S1 Fig this was corroborated by MCHC decrease (32.2 ± 0.3g/dL vs 26.7 ± 0.3g/
dL; p<0.05; S1 Fig), corresponding to observed spherocytic morphology (SEM). Glycerolization
also increased RDW, compared to fresh RBCs (34.5 ±0.8% vs 13 ± 0.3%, respectively; p<0.05; S1
Fig). Following full deglycerolization, all parameters returned to levels observed for fresh RBCs.
In vitro physiologic measurements
Cell volume regulation (osmotic fragility). When measured immediately following
deglycerolization, storage in glycerol and full deglycerolization increased RBC osmotic fragility
(i.e., cells lysed at a higher tonicity [in NaCl solution] in comparison to fresh RBCs); the half-
maximal effective NaCl concentration [EC50] increased (from 4.39 ± 0.09g/L to 4.66 ± 0.07g/L,
p<0.05; Fig 3B and 3C). However, resting RBCs in the last deglycerolization buffer (1h, 37˚C)
restored osmotic resilience to levels observed in fresh RBCs (4.39 ± 0.09g/L to 4.37 ± 0.09g/L;
Fig 3B and 3C).
Deformability. Deformability of deglycerolized and fresh RBCs was identical across a
physiologically relevant range of shear stress (Fig 3D). The shear stress at which RBCs demon-
strated 50% elongation (SS50) was did not differ between fresh and deglycerolized RBCs (fol-
lowing prolonged buffer immersion) (Fig 3E).
Adhesion. A trend was observed toward decreased ex vivo RBC adhesivity in deglycero-
lized compared to fresh RBCs, across all sheer stresses >1dyne/cm2; this did not reach statisti-
cal significance (Fig 3F).
O2 affinity. No difference was observed in the O2-hemoglobin dissociation curves from
matched fresh and deglycerolized RBC samples (BIS TRIS 50mM, NaCl, 100mM) (Fig 4A),
nor in p50, cooperativity (Fig 4B) and Bohr effect (Fig 4C).
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RBC-based hypoxic vasodilatory response. In an organ-chamber bioassay of endothe-
lium-intact rabbit aortic rings held at low O2 tension (~1% O2), matched fresh and deglycero-
lized RBCs demonstrated similar vasodilation (Fig 4E). Single representative traces were
plotted to visually demonstrate the relaxation response (Fig 4D).
RBC NO content. Photolysis-chemiluminescence was used to measure RBC hemoglobin
NO content in matched: fresh, frozen (without glycerol) and cryopreserved RBCs (without/
with glycerol removal). Total Hb NO content was not significantly different between any of
Fig 3. RBC morphological imaging (scanning electron microscope; SEM) and comparison of osmotic fragility, deformability, and ex vivo adhesion in
matched fresh and deglycerolized RBCs. (A) Illustration of the characteristic biconcave disc morphology of fresh RBCs. Following glycerol addition, the
majority of RBCs become swollen and spherocytic. After thawing, RBCs remain encapsulated in a glycerol matrix. Following deglycerolization RBCs return to
their original morphology. (B) NaCl induced osmotic lysis in matched fresh, deglycerolized, and deglycerolized RBCs exposed to a prolonged buffer incubation
(n = 5 or 10 individual donors, shown on graph). NaCl induced osmotic lysis increased immediately following deglycerolization, but returned to the original fresh
phenotype following prolonged incubation (1 hour) of RBCs in the final deglycerolization buffer. (C) Half maximal effective concentration (EC50) increased
immediately following deglycerolization, in comparison to fresh RBC samples (p< 0.05). However, prolonged incubation (1 hour) of RBCs in the final
deglycerolization buffer at 37˚C restored the original fresh RBC phenotype (n = 5 or 10 individual donors, shown on graph). (D) Shear induced maximal RBC
deformability (Elongation Index maximum; EImax) was not different between matched fresh and deglycerolized RBCs (exposed to the prolonged buffer
immersion) (n = ±6 individual donors). (E) The shear stress (Pa) at which RBC demonstrated 50% elongation (SS50) was also not different between matched fresh
and deglycerolized RBCs (exposed to the prolonged buffer immersion) (n = 6 individual donors). (F) RBC adhesivity to endothelium was determined ex vivo. A
trend was observed toward a decrease in RBC adhesivity in the deglycerolized RBCs, across all sheer stresses> 1 dyne/cm2, that did not reach statistical
significance.
https://doi.org/10.1371/journal.pone.0209201.g003
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the conditions, although freezing (regardless of glycerol addition) appeared to slightly augment
NO levels (Fig 4F). Iron nitrosyl hemoglobin (HbFeNO) content remained unchanged in all
conditions (Fig 4G). However, S-nitrosohemoglobin (SNO-Hb) levels increased upon sample
freezing (Fig 4H), independent of glycerol presence or removal (fresh: 0.0038 ± 0.001; frozen:
0.0095 ± 0.002; cryopreserved w/o deglycerolization: 0.011 ± 0.001; cryopreserved, deglycero-
lized: 0.010 ± 0.002; expressed as NO:Hb molar ratio; tetramer basis, for all; p<0.05).
Biochemical analysis
Metabolomics–steady state phenotypes and metabolic fluxes in response to oxidant
stress. UHPLC-MS metabolomics were performed to compare phenotypes of fresh vs
Fig 4. Comparison of O2 dissociation curves (ODCs) and RBC hypoxic vasodilatory response (HVD) from matched fresh and deglycerolized RBCs, and NO
content of matched fresh RBCs, frozen RBCs (without glycerol), cryopreserved RBCs (without glycerol removal), and cryopreserved RBCs (deglycerolized),
measured by photolysis:chemiluminescence. (A) Raw ODC curves from matched fresh and deglycerolized RBCs in BIS TRIS buffer (BIS TRIS 50mM, NaCl,
100mM), pH to 7.2, 7.4, and 7.6. Inset is the whole ODC curve (n = 10 individual donors). No difference was observed between fresh and deglycerolized RBCs. (B)
Hill coefficient, a measure of cooperativity, was not different between matched fresh and deglycerolized RBC samples across the 3 different pH values. (C) Bohr
plot demonstrates no change between matched fresh and deglycerolized RBC samples. (D) Representative single traces (from rings demonstrating similar PE
constriction responses) of the relaxation responses from fresh vs deglycerolized RBCs under hypoxia (~ 1% O2)—Arrow indicates injection point for RBCs. (E)
Relaxation responses of fresh and deglycerolized RBCs (as a percentage of maximal constriction) are not different in a hypoxic organ chamber bioassay of
endothelial intact rabbit aortic rings. (F) Total RBC NO content was not significantly different between any of the conditions, although freezing appeared to slightly
augment NO levels. (G) Iron nitrosyl hemoglobin (HbFeNO) content remained unchanged in all conditions. (H) S-nitrosohemoglobin (SNO-Hb) significantly
increased upon freezing, independent of glycerol presence (p< 0.05). Data reported as NO:Hb (tetramer basis).
https://doi.org/10.1371/journal.pone.0209201.g004
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cryopreserved and deglycerolized RBCs (Fig 5A–5H). Analyses of both RBCs and media indi-
cated similar glucose consumption rates (Fig 5D and 5F) and total lactate generation (Fig 5E
and 5G) in both groups over a 6h time course. Oxidative loading (SOTS-1) was employed to
unveil more subtle metabolic differences between fresh and deglycerolized RBCs, by extending
the dynamic range for metabolite flux. Supplementation to the media of [1,2,3-13C3]glucose
was used to determine the rate of lactate isotopologue enrichment via glycolysis (M+3) or the
pentose phosphate pathway (M+2). Results indicated that fresh RBCs were characterized by
significantly higher levels of supernatant–but not intracellular—M+2 lactate (Fig 5H). Con-
versely, deglycerolized RBCs were characterized by faster glycolysis than fresh RBCs (Fig 5H).
Even though lower lactate M+2 export in deglycerolized RBCs following SOTS-1 was ob-
served, intracellular glycolysis to pentose phosphate pathway ratios were comparable between
fresh and deglycerolized RBCs following treatment with SOTS-1 (Fig 5H). Deglycerolized
RBCs were also characterized by lower levels of oxidized glutathione (GSSG) and higher
reduced to oxidized glutathione ratios (GSH/GSSG) in comparison to fresh RBCs treated with
SOTS-1, suggestive of decreased oxidative damage upon oxidative loading, in comparison to
SOTS-1-treated fresh RBCs (not shown).
Considering the minor differences noted in (above) tracing exeperiments, to further com-
pare the metabolic phenotypes of fresh and cryopreserved RBCs, we performed unsupervised
analyses of metabolomics data via PLS-DA (Fig 6A) and hierarchical clustering. Dendrograms
for time course data from control vs DG +/- SOTS-1 are shown in Fig 6B. The impact of time
and oxidative loading (SOTS-1) informed sample clustering along principal components 1
and 2 (explaining 21.9 and 17.4% of the total variance, respectively). Both PLS-DA and hierar-
chical clustering analyses confirmed that control and DG groups fell into identical clusters at
the tested time points, both in the absence and presence of SOTS (Fig 6A and 6B). Results are
further shown in the form of heat maps (Fig 6C and S2 Fig), visually indicating a time course
and SOTS-1 dependency of the metabolic phenotypes observed both in control and DG
groups. The only notable exception was glycerol-phosphate, a product of glycerol metabolism,
observed to be significantly higher in DG RBCs at 0h time point and declining to 0h control
levels just after 6h.
In vivo RBC analysis
RBC response to transfusion in nude mice (mapped hemoglobin O2 saturation, RBC
velocity, and RBC adhesion). Post-transfusion function of human RBCs was assessed in a
nude mouse model (Fig 7A), with comparison made between fresh or deglycerolized RBCs.
Labeled human RBCs were transfused into healthy nude mice in volumes mimicking a 2-unit
transfusion in an adult human. As described[58, 59], control fresh healthy human RBCs did
not alter blood hemoglobin O2 saturation maps. There was also no effect on (transfused) RBC
velocity. Adhesion of control transfused human RBCs in vivo was low, and adhesion of trans-
fused DG RBCs did not differ significantly.
We found that the cryopreservation protocol did not alter mapped hemoglobin O2 satura-
tion in a dorsal skinfold window chamber model either qualitatively or in quantitative Hb sat-
uration analysis (Fig 7B and 7C), nor was RBC velocity altered (Fig 7D). There was a modest
but statistically insignificant effect of cryopreservation on in vivo adhesivity of transfused
RBCs (Fig 7E), as compared to that of fresh human RBCs from the same donors.
Discussion
Here, we report a RBC cryopreservation protocol optimized to satisfy requirements particular
to RBC research. This protocol improved glycerolization efficiency (~40% time reduction to
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Fig 5. Comparison of metabolomic steady state phenotypes and metabolic fluxes in response to oxidant stress in
fresh and matched deglycerolized RBCs. (A) Tracing experiments were performed by incubating RBCs with
[1,2,3-13C3]glucose, a heavy substrate that can be metabolized in RBCs through (B) the Embden-Meyerhof-Parnas
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achieve 40% v/v, glycerol final) and was equivalent to the standard method[28, 38, 39] in terms
of RBC recovery following freezing (-80˚C) and thawing (37˚C). Of note, following full glyc-
erol removal (>99.9%), our modified procedure reduced total cumulative lysis by ~35%, in
comparison to the standard method. These improvements minimize the burden of initial sam-
ple processing, render cryopreservation protocols more feasible for clinical research staff,
improve RBC recovery following cryopreservation and enable analyses of vulnerable RBC sub-
populations that might otherwise be lost. Our modified methodology resulted in a post-cryo-
preservation/deglycerolization RBC phenotype that was indistinguishable from that of fresh
RBCs, with regard to physical RBC parameters (morphology, volume, and density), osmotic
fragility, deformability, endothelial adhesivity, O2 affinity, vasoregulation, metabolomics, and
flow dynamics.
In the process of inter-laboratory method validation, we noted that sample handling during
both the glycerolization and deglycerolization procedures influenced RBC lysis amount. Others
[34] have also reported that RBC sample processing contributes more to cryostored RBC quality
than does storage duration. Specificially, we determined that when adding packed RBCs to gly-
cerolizing solutions, immediate gentle sample inversion (to fully suspend cells) was necessary to
prevent RBC clumping and greater post-thaw lysis. Similarly, throughout the deglycerolization
procedure, lysis was increased by excessive agitation or tube plucking/tapping to accelerate RBC
re-suspension. Ultimately, simple rotation of the tube on its axis (to mix the sample) proved
optimal. We did not address the effect of storage duration on RBC recovery or phenotype fidel-
ity, as all samples were analyzed and measured within a month of freezing.
Our cryopreservation protocol was specifically developed for maximal recovery of human
RBCs. It should be noted that plasma osmolality[60–62] as well as RBC size and volume (and
subsequently surface area to volume ratios)[63–68] differ widely across species commonly
used in RBC research, all of which may contribute to differing tolerance to osmotic and
mechanical stress. It is thus likely that species-specific adjustments to this cryopreservation
protocol may be needed to attain similar results. Additionally, even with human RBCs, we still
observed 8% lysis following cryopreservation. We speculate that the cells lost may represent
cells or cell sub-population(s) least resilient to osmotic or mechanical stress, suggesting possi-
ble need for additional method validation prior to study of subjects with such pathologies.
With this in mind, while we focused on glycerol as our CPA due to its lack of toxicity and
extensive literature on its clinical use, other cryoprotectants are available (both cell-penetrating
and non-cell penetrating) that might better address this issue.
The finding that there was a small degree of baseline adhesion of control transfused human
RBCs is in agreement with prior published findings[58, 59]. It is possible that the slightly larger
(EMP) glycolytic pathway (generating isotopologue M+3) or through the pentose phosphate pathway (PPP), generating
isotopologue M+2 of lactate, (C) owing to the release of the first carbon atom of heavy glucose in the form of 13CO2 at
the oxidative phase reactions of the PPP. (F) Schematic overview of glucose uptake and consumption in RBC
supernatants and cells, in fresh, or deglycerolized RBCs, either untreated, or treated with the superoxide generator
(SOTS-1), (D) demonstrating in both RBCs and media similar glucose consumption rates. (E) Total lactate, i.e., sum of
lactate isotopologues (unlabeled M+0, M+3 generated via glycolysis, or M+2 generated via the PPP), in fresh and DG
RBCs, either untreated or treated with the superoxide generator (SOTS-1), demonstrating in both RBCs and media
similar lactate accumulation. (G and H) Schematic overview of expected isotopologues and relative ratios of lactate,
from glycolysis (EMP, M+3 isotopologue) or PPP (M+2) and relative ratios in fresh and DG RBCs, either untreated, or
treated with the supoxide generator SOTS-1. (H) Fresh RBCs were characterized by significantly higher levels of
supernatant–but not intracellular—M+2 lactate. Conversely, deglycerolized RBCs were characterized by faster
glycolysis than fresh RBCs. Lower lactate M+2 export in deglycerolized RBCs following SOTS-1 was observed, while
intracellular glycolysis to pentose phosphate pathway ratios were comparable between fresh and deglycerolized RBCs
following treatment with SOTS-1. Continuous lines indicate median, while dashed lighter lines are representative of
interquartile ranges, according to the color legend left. Symbols indicate p<0.05 + = fresh vs DG; & = fresh + SOTS vs
DG + SOTS; � = fresh vs fresh + SOTS; # = DG vs DG + SOTS.
https://doi.org/10.1371/journal.pone.0209201.g005
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size of human red cells may lead to pseudostatic appearance in mouse capillaries, where some
fraction of the transfused RBCs might require a slightly longer transit time. In addition, there
may be infrequent, random adhesion of even murine RBCs to murine (or human to human)
endothelium in vivo. The adapted cryopreservation technique did not increase RBC adhesivity.
Unsupervised analyses of metabolomics data confirmed similarity of metabolic phenotypes
of fresh and deglycerolized RBCs, both at rest and under oxidant loading conditions, affirming
the conclusion that our research-optimized procedure for RBC cryopreservation and deglycer-
olization in 40% v/v glycerol final does not significantly impact RBC phenotype (compared to
fresh cells).
Fig 6. Unsupervised analysis of metabolomics data via PLS-DA, with dendrograms for time course hierarchical clustering and heat maps, visually indicating
a time course and SOTS dependency of the metabolic phenotypes observed in fresh RBC and matched DG RBCs. (A) The impact of time and SOTS treatment
informed sample clustering along principal components 1 and 2 (explaining 21.9 and 17.4% of the total variance, respectively). Both (A) PLS-DA and (B)
hierarchical clustering analyses confirmed that control and DG groups fell into the same clusters at the tested time points, both in the absence and presence of
SOTS. (C) Heat maps visually indicate the time course and SOTS dependency of the metabolic phenotypes observed both in fresh RBC and DG groups.
https://doi.org/10.1371/journal.pone.0209201.g006
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Fig 7. Dorsal window chamber set up for the assessment of in vivo hemoglobin O2 saturation, RBC velocity and vascular adherence of transfused fresh or
matched deglycerolized RBCs. (A) Image of the dorsal window chamber set up. (B and C) No difference was observed in mapped hemoglobin O2 saturation, or
(D) RBC velocity in the dorsal skinfold window chamber model, between the transfusion of fresh or deglycerolized RBCs. (E) A modest, but statistically
insignificant difference was observed on in vivo adhesivity of transfused RBCs between fresh and deglycerolized RBCs from the same donors.
https://doi.org/10.1371/journal.pone.0209201.g007
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